Tapering Considerations: Gradually reduce GLP-1 dosing while increasing fiber and protein intake Begin nutraceutical support (e.g., berberine, chromium) 24 weeks prior to taper Monitor lean mass and glycemic variability Support appetite signaling with mindful eating and circadian regulation Address gut motility and emotional eating patterns with botanical support Clinical Example: A Case in Practice A 52-year-old female on semaglutide for 6 months presented with nausea, fatigue, and concern about lean mass loss
GLP-1 and GGG medications All GLP-1 medications mimic the naturally occurring gut hormone GLP-1 in an effort to help lower blood sugar and decrease appetite
Back Brown, JC, Mutt, V, Pederson, RA (July 1970) 'Further purification of a polypeptide demonstrating enterogastrone activity', The Journal of Physiology , 209/1
10.2337/diab.47.8.1253 27
K.NakhateS
Site rotation is critical for both bruising prevention and medication absorption consistency
